Ruvise Trademark Details
Word Mark | Ruvise |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Serial Number | 78238664 |
---|---|
Status Date | Sunday, February 25, 2007 |
Filing Date | Sunday, February 25, 2007 |
Attorney | Eliane Setton, |
Correspondent
Allyn Taylor, Esq.
DLA Piper US LLP
2000 University Avenue
East Palo Alto CA 94303-2215
DLA Piper US LLP
2000 University Avenue
East Palo Alto CA 94303-2215
Case File Statements
Goods & Services | Pharmaceutical Preparations for the Treatment of Cardiovascular Diseases and Disorders, Oncological Diseases and Disorders, Immune Diseases and Disorders, Angiogenesis Diseases and Disorders, Ocular Diseases and Disorders, or Inflammatory Diseases and Disorders |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Thursday, April 24, 2003 |
Primary Code | 005 |
Trademark Timeline
-
Apr 17 2003Trademark application filed with USPTO
-
Sep 22 2003Approved For Pub - Principal Register
-
Sep 22 2003Assigned To Examiner
-
Nov 12 2003Notice of Publication
-
Nov 18 2003Teas Change of Correspondence Received
-
Dec 02 2003Published For Opposition
-
Dec 15 2003Paper Received
-
Feb 24 2004Noa Mailed - Sou Required From Applicant
-
Jul 05 2004Teas Change of Correspondence Received
-
Jul 28 2004Extension 1 Granted
-
Jul 28 2004Extension 1 Filed
-
Jul 28 2004Teas Extension Received
-
Jan 31 2005Extension 2 Filed
-
Jan 31 2005Teas Extension Received
-
Feb 16 2005Extension 2 Granted
-
Feb 18 2005Teas Change of Correspondence Received
-
Aug 04 2005Extension 3 Granted
-
Aug 04 2005Extension 3 Filed
-
Aug 04 2005Teas Extension Received
-
Feb 01 2006Extension 4 Granted
-
Feb 01 2006Extension 4 Filed
-
Feb 01 2006Teas Extension Received
-
Jul 31 2006Extension 5 Granted
-
Jul 31 2006Extension 5 Filed
-
Jul 31 2006Teas Extension Received
-
Sep 19 2006Teas Change of Correspondence Received
-
May 03 2007Abandonment Notice Mailed - No Use Statement Filed
-
May 03 2007Abandonment - No Use Statement Filed